| Antifungal susceptibility testing: practical aspects and current challenges JH Rex, MA Pfaller, TJ Walsh, V Chaturvedi, A Espinel-Ingroff, ... Clinical microbiology reviews 14 (4), 643-658, 2001 | 632 | 2001 |
| Emergence and pathogenicity of highly virulent Cryptococcus gattii genotypes in the northwest United States EJ Byrnes 3rd, W Li, Y Lewit, H Ma, K Voelz, P Ren, DA Carter, ... PLoS Pathog 6 (4), e1000850, 2010 | 362 | 2010 |
| Correlation of MIC with Outcome for Candida Species Tested against Voriconazole: Analysis and Proposal for Interpretive Breakpoints MA Pfaller, DJ Diekema, JH Rex, A Espinel-Ingroff, EM Johnson, D Andes, ... Journal of clinical microbiology 44 (3), 819-826, 2006 | 326 | 2006 |
| Clinical and Laboratory Standards Institute JH Rex, BD Alexander, D Andes, B Arthington-Skaggs, SD Brown, ... M27-A3. Reference method for broth dilution antifungal susceptibility …, 2008 | 320 | 2008 |
| Correlation of MIC with Outcome for Candida Species Tested against Caspofungin, Anidulafungin, and Micafungin: Analysis and Proposal for Interpretive MIC … MA Pfaller, DJ Diekema, L Ostrosky-Zeichner, JH Rex, BD Alexander, ... Journal of clinical microbiology 46 (8), 2620-2629, 2008 | 290 | 2008 |
| Projecting global occurrence of Cryptococcus gattii DJ Springer, V Chaturvedi Emerging infectious diseases 16 (1), 14, 2010 | 240 | 2010 |
| Oxidative killing of Cryptococcus neoformans by human neutrophils. Evidence that fungal mannitol protects by scavenging reactive oxygen intermediates. V Chaturvedi, B Wong, SL Newman Journal of immunology (Baltimore, Md.: 1950) 156 (10), 3836-3840, 1996 | 227 | 1996 |
| Optimal testing conditions for determining MICs and minimum fungicidal concentrations of new and established antifungal agents for uncommon molds: NCCLS collaborative study A Espinel-Ingroff, V Chaturvedi, A Fothergill, MG Rinaldi Journal of clinical microbiology 40 (10), 3776-3781, 2002 | 177 | 2002 |
| Efficacy of API 20C and ID 32C systems for identification of common and rare clinical yeast isolates R Ramani, S Gromadzki, DH Pincus, IF Salkin, V Chaturvedi Journal of Clinical Microbiology 36 (11), 3396-3398, 1998 | 171 | 1998 |
| Prospective Study of Candida Species in Patients at a Comprehensive Cancer Center A Safdar, V Chaturvedi, EW Cross, S Park, EM Bernard, D Armstrong, ... Antimicrobial agents and chemotherapy 45 (7), 2129-2133, 2001 | 167 | 2001 |
| Clinical breakpoints for voriconazole and Candida spp. revisited: review of microbiologic, molecular, pharmacodynamic, and clinical data as they pertain to the development of … MA Pfaller, D Andes, MC Arendrup, DJ Diekema, A Espinel-Ingroff, ... Diagnostic microbiology and infectious disease 70 (3), 330-343, 2011 | 157 | 2011 |
| Intra-and interlaboratory study of a method for testing the antifungal susceptibilities of dermatophytes MA Ghannoum, V Chaturvedi, A Espinel-Ingroff, MA Pfaller, MG Rinaldi, ... Journal of clinical microbiology 42 (7), 2977-2979, 2004 | 150 | 2004 |
| Wild-Type MIC Distribution and Epidemiological Cutoff Values for Aspergillus fumigatus and Three Triazoles as Determined by the Clinical and Laboratory … MA Pfaller, DJ Diekema, MA Ghannoum, JH Rex, BD Alexander, D Andes, ... Journal of clinical microbiology 47 (10), 3142-3146, 2009 | 147 | 2009 |
| Fusarium: more than a node or a foot-shaped basal cell PW Crous, L Lombard, M Sandoval-Denis, KA Seifert, HJ Schroers, ... Studies in mycology 98, 100116, 2021 | 141 | 2021 |
| Candida auris isolates resistant to three classes of antifungal medications—New York, 2019 B Ostrowsky, J Greenko, E Adams, M Quinn, B O’Brien, V Chaturvedi, ... Morbidity and Mortality Weekly Report 69 (1), 6, 2020 | 137 | 2020 |
| Morphological and molecular characterizations of psychrophilic fungus Geomyces destructans from New York bats with white nose syndrome (WNS) V Chaturvedi, DJ Springer, MJ Behr, R Ramani, X Li, MK Peck, P Ren, ... PloS one 5 (5), e10783, 2010 | 134 | 2010 |
| Cryptococcus gattii: a resurgent fungal pathogen V Chaturvedi, S Chaturvedi Trends in microbiology 19 (11), 564-571, 2011 | 132 | 2011 |
| Characterization of Cryptococcus neoformans variety gattii SOD2 reveals distinct roles of the two superoxide dismutases in fungal biology and virulence SD Narasipura, V Chaturvedi, S Chaturvedi Molecular microbiology 55 (6), 1782-1800, 2005 | 132 | 2005 |
| Characterization of Cu,Zn superoxide dismutase (SOD1) gene knock‐out mutant of Cryptococcus neoformans var. gattii: role in biology and virulence SD Narasipura, JG Ault, MJ Behr, V Chaturvedi, S Chaturvedi Molecular microbiology 47 (6), 1681-1694, 2003 | 131 | 2003 |
| A diverse population of Cryptococcus gattii molecular type VGIII in southern Californian HIV/AIDS patients. no. 9 (2011): e1002205. Byrnes, Edmond J., Wenjun Li, Ping Ren, Yonathan ... PLoS Pathog 7 (9), e1002205, 2011 | 129 | 2011 |
